Exact peptide identities attached to retained registry observations carrying this condition label.
Official registry condition
Acromegaly peptide trials
6 selected ClinicalTrials.gov records carrying the official condition label Acromegaly. The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.
6 selected records.
3 profiles.
2018–2024 in selected records.
Indication intelligence
Selected evidence landscape
Phase labels copied from the retained ClinicalTrials.gov versions.
Overall statuses at each retained observation, not necessarily current today.
Across the connected peptide profiles, PeptideScanner also carries 143 selected PubMed records and 32 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern Acromegaly unless their own cited source says so.
Collection change ledger
Recently changed records on this condition hub
These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.
ClinicalTrials.gov record NCT00171730
PeptideScanner retained ClinicalTrials.gov record NCT00171730 at 2026-11-15T22:05:38.400Z. Its registry update date was 2021-09-05, and PeptideScanner's reviewed identity mapping was pasireotide.
- PeptideScanner change date
- November 15, 2026
- Cited source date
- September 5, 2021
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT00446082
PeptideScanner retained ClinicalTrials.gov record NCT00446082 at 2026-11-15T22:05:38.400Z. Its registry update date was 2020-12-21, and PeptideScanner's reviewed identity mapping was pasireotide.
- PeptideScanner change date
- November 15, 2026
- Cited source date
- December 21, 2020
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT01137682
PeptideScanner retained ClinicalTrials.gov record NCT01137682 at 2026-11-15T22:05:38.400Z. Its registry update date was 2018-04-05, and PeptideScanner's reviewed identity mapping was pasireotide.
- PeptideScanner change date
- November 15, 2026
- Cited source date
- April 5, 2018
- Evidence lane
- Clinical trials
Attributed registry records
Selected records
Pasireotide · 2024-10-01
ClinicalTrials.gov record NCT01794793
Completed at the retained observation.
Open attributed record →Pasireotide · 2021-09-05
ClinicalTrials.gov record NCT00171730
Completed at the retained observation.
Open attributed record →Pasireotide · 2020-12-21
ClinicalTrials.gov record NCT00446082
Completed at the retained observation.
Open attributed record →Lanreotide · 2019-01-29
ClinicalTrials.gov record NCT02493517
Completed at the retained observation.
Open attributed record →Pasireotide · 2018-04-05
ClinicalTrials.gov record NCT01137682
Completed at the retained observation.
Open attributed record →Octreotide · 2018-02-15
ClinicalTrials.gov record NCT02217800
Completed at the retained observation.
Open attributed record →